Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,933
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
for
EDS, Cataplexy, Fatigue, Narcolepsy
Location: Dallas TX, Austin TX, Sugar Land TX, San Antonio TX,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07675135
Phase 3, Recruiting
Active & Responsive
Wearable Photoplethysmography for Non-invasive Hydration Assessment
for
Hydration Status
Location: Frisco TX, Plano TX
Sponsor: PepsiCo Global R&D
Sex: All
Age: 18 - 45
Code: NCT07520344
Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Dallas TX, Houston TX, Little Rock AR, Jackson MS,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase 3, Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
for
Lymphoid Leukemia
Location: Dallas TX, Fort Worth TX, St Louis MO, Chicago IL,
Sponsor: Stanford University
Sex: All
Age: 0 - 26
Code: NCT05865301
Recruiting
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Dallas TX, Kansas City KS, St Louis MO, Birmingham AL,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
for
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness,
Location: Dallas TX, Chicago IL, Madison WI, Pittsburgh PA,
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension